The Trump administration is considering mandating insurers to disclose their negotiated rates for hospital services. This follows a proposal earlier this year that would require hospitals and physicians to inform patients of the full cost of care prior to care being administered.
Search Results for:
In 1921, University of Toronto scientists discovered insulin, the pancreas-produced hormone that breaks down sugar in the blood. They quickly purified it, injected it into children dying from Type 1 diabetes, and were hailed as the first great miracle-makers of modern medicine.
There have been many improvements to animal-derived insulin over the years. In 1982, the Food and Drug Administration approved the first DNA-based human insulin.
When it comes to the prescription drugs America use, too often money is the last thing consumers think about. Formulaic prescription drug ads are part of the reason why.
Suffer from blood clotting or find yourself at an elevated risk of stroke due to an irregular heartbeat? Then Eliquis is your answer. Got moderate to severe ulcerative colitis, psoriatic arthritis or Crohn’s disease? Then talk to your doctor about Humira.
We agree patients should have more transparency about medicine costs. That is why our member companies have taken a new approach to direct-to-consumer television advertising and began voluntarily directing patients to links to comprehensive cost information in their DTC television advertising.
It is also why we partnered with consumer, patient, pharmacist and provider groups to launch a new platform called the Medicine Assistance Tool at MAT.org. This tool links to the websites referenced in company DTC television advertising and includes a search tool to help patients connect to financial assistance programs.
The Chair and Ranking Member of the House Energy and Commerce Committee, Reps. Pallone (D-NJ) and Walden (R-OR), released draft legislation to address the issue of surprise billing and asked stakeholders to submit comments by May 28. CHA sent a letter to the California congressional delegation outlining our priorities.
The California Department of Public Health (CDPH) earlier this week released All Facilities Letter 19-19, which updates its application process for new or remodeled pharmacy clean rooms and mobile sterile compounding units (MSCUs). Notably, CDPH will no longer accept incomplete applications for pharmacy clean rooms or MSCUs. CDPH states the update is in response to Assembly Bill 2978 (Chapter 992, Statutes of 2018), which requires CDPH to review or deny applications within 100 days of receipt.
What’s new in CHA Education? On-demand learning!
CHA is now offering members-only on-demand programs that provide the knowledge you need, on your time schedule. How much time can you spare for learning in a day — 15 minutes? Three hours? The choice is yours.
Take a look at what we have available and make sure to check back frequently for updates to our library of topics.
Thanks to the state’s embrace of Obamacare, California has expanded health insurance to millions of uninsured residents over the last five years. But as the number of people covered has grown, so has the strain on the doctors, clinics and hospitals that must respond to the increasing demand for care.
The problem is especially acute when it comes to primary care doctors and other front-line care providers, such as physician assistants and nurse practitioners. A study by UC San Francisco estimated that the state will have a shortfall of 4,700 of these clinicians by 2025. And the California Future Health Workforce Commission warned earlier this year: “Seven million Californians, the vast majority of them Latino, black and Native American, live in Health Professional Shortage Areas — a federal designation for counties experiencing shortfalls of primary care, dental care or mental health care providers.”
Once again, the nation’s safety net is staring down a severe cut to Medicaid disproportionate-share hospital funding, as it has almost every year since 2014. This time, hospitals and their vulnerable patients face a $4 billion reduction Oct. 1 that would slash one-third of the program’s funding in one year.
So Congress again must consider an action it has taken four times already since the cuts were scheduled to start: delay them. Previous delays enjoyed strong bipartisan support, and that’s clearly the case again this year—even as some question whether another delay just kicks the can down the road.